Fischer Medical Ventures and The Therapy Platform partner for mental healthcare
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
For use with Hamamatsu Images acquired with the NanoZoomer S360MD slide scanner
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
The company plans to add 1700 beds by FY27 through the organic route
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
WINREVAIR is a breakthrough biologic for this rare, progressive disease
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Subscribe To Our Newsletter & Stay Updated